ATE35827T1 - Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen. - Google Patents

Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE35827T1
ATE35827T1 AT83304310T AT83304310T ATE35827T1 AT E35827 T1 ATE35827 T1 AT E35827T1 AT 83304310 T AT83304310 T AT 83304310T AT 83304310 T AT83304310 T AT 83304310T AT E35827 T1 ATE35827 T1 AT E35827T1
Authority
AT
Austria
Prior art keywords
lymphotoxin
derivatives
preparation
same
pharmaceutical compositions
Prior art date
Application number
AT83304310T
Other languages
English (en)
Inventor
Bharat Bhushan Aggarwal
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE35827T1 publication Critical patent/ATE35827T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT83304310T 1982-07-30 1983-07-26 Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen. ATE35827T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40367182A 1982-07-30 1982-07-30
EP83304310A EP0100641B1 (de) 1982-07-30 1983-07-26 Menschliches Lymphotoxin und seine Derivate, Verfahren zu seiner Herstellung und dasselbe enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE35827T1 true ATE35827T1 (de) 1988-08-15

Family

ID=23596593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83304310T ATE35827T1 (de) 1982-07-30 1983-07-26 Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen.

Country Status (9)

Country Link
EP (1) EP0100641B1 (de)
JP (2) JPH0716435B2 (de)
AT (1) ATE35827T1 (de)
AU (1) AU573531B2 (de)
CA (1) CA1241597A (de)
DE (1) DE3377421D1 (de)
DK (1) DK170713B1 (de)
IE (1) IE55553B1 (de)
ZA (1) ZA834976B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59141519A (ja) * 1983-01-31 1984-08-14 Otsuka Pharmaceut Co Ltd 制ガン作用を有する蛋白質
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
ATE48617T1 (de) * 1984-04-13 1989-12-15 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.
US4708948A (en) * 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
JPS60243018A (ja) * 1984-05-17 1985-12-03 Yamanouchi Pharmaceut Co Ltd ヒト内来性癌制御因子
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
NZ212207A (en) * 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPS6124520A (ja) * 1984-07-12 1986-02-03 Takeshi Makitsubo 腫瘍壊死因子様物質を抽出する方法
JPS6156131A (ja) * 1984-07-17 1986-03-20 Takeshi Makitsubo 腫瘍壊死因子様物質
EP0178050A1 (de) * 1984-08-13 1986-04-16 The Wellcome Foundation Limited Eiweisssubstanz
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
US4677063A (en) * 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4708937A (en) * 1984-10-15 1987-11-24 Brigham & Women's Hospital Purified migration inhibitory factor also having colony stimulating factor activity
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
PT81823B (pt) * 1985-01-14 1987-11-30 Yamanouchi Pharma Co Ltd Metodo de preparacao de factores endogenos humanos reguladores de cancro
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin
EP0205038A1 (de) * 1985-05-29 1986-12-17 Suntory Limited Polypeptid, Verfahren zu dessen Herstellung, Mikroorganismus und pharmazeutische Verwendung
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインｉｉｉとその製法
JPS62298536A (ja) * 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
DE3907244A1 (de) * 1989-03-07 1990-09-13 Knoll Ag Erzeugnisse, enthaltend ein lithiumsalz und einen tumor-nekrose-faktor

Also Published As

Publication number Publication date
DE3377421D1 (en) 1988-08-25
IE831786L (en) 1984-01-30
AU573531B2 (en) 1988-06-16
DK348083D0 (da) 1983-07-29
EP0100641A3 (en) 1984-05-02
CA1241597A (en) 1988-09-06
DK348083A (da) 1984-01-31
EP0100641B1 (de) 1988-07-20
DK170713B1 (da) 1995-12-18
JPH07188295A (ja) 1995-07-25
AU1723983A (en) 1984-02-02
JPH0716435B2 (ja) 1995-03-01
IE55553B1 (en) 1990-10-24
JPS5984827A (ja) 1984-05-16
EP0100641A2 (de) 1984-02-15
JP2524969B2 (ja) 1996-08-14
ZA834976B (en) 1984-08-29

Similar Documents

Publication Publication Date Title
ATE35827T1 (de) Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen.
ATE7697T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
ATE8790T1 (de) Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ZA782026B (en) Improvements in the process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing same
PT79840A (en) Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith
DE19775011I2 (de) Chinolinderivate Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekaempfung unerwuenschten Planzenwuchses
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
DK422583A (da) Fremgangsmaade til fremstilling af diazobicyclo-(3,3,1)-nonaner
ES8307210A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1, omega-difenil-aza-alcano.
DE19975037I2 (de) 3H-Imidazo-5,1-d-1,2,3,5-tetrazin-4-on-Derivate Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK153545C (da) Analogifremgangsmaade til fremstilling af n-substituerede derivater af 3,4,5-trihydroxy-2-hydroxymethyl-piperidin
ATA78476A (de) Enossales implantat zur befestigung von festsitzendem zahnersatz, vorrichtung zum passgenauen herstellen von ausfraesungen dafuer sowie versenkinstrument zum versenken des implantats
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
SE8002831L (sv) Oxitetracyklinberedningar
IT7850986A0 (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonche'composizioni farmaceutiche che la contengono
EP0207287A3 (de) Indolinderivate, Verfahren zu ihrer Herstellung und diese Indolinderivate enthaltende kosmetische Lichtschutzmittel
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
ES485992A1 (es) Procedimiento para la obtencion de un fungicida a base de carboximidas y derivados sulfamidicos
EP0091057A3 (en) 5,6-dihydro-11-alkylene-mophantridin-6-ones, process for their preparation and pharmaceutical compositions containing them
PT71673B (de) 2-sulfinyl-5-sulfonyl-1,3,4-thiadiazolderivate verfahren zur herstellung dieser verbindungen sowie diese enthaltendefungizide mittel
ATE5315T1 (de) Substituierte caprylolactam-derivate als antihypertonika, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time